These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 6807339)

  • 21. Recent findings in understanding the biological function of vitamin K.
    Uotila L; Suttie JW
    Med Biol; 1982 Feb; 60(1):16-24. PubMed ID: 6803084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3-Methylcholanthrene induction of enzymes in the vitamin K-dependent carboxylation system.
    Wallin R; Patrick SD; Martin LF
    Biochem Pharmacol; 1987 Dec; 36(24):4303-6. PubMed ID: 3120735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical basis of warfarin and bromadiolone resistance in the house mouse, Mus musculus domesticus.
    Misenheimer TM; Lund M; Baker EM; Suttie JW
    Biochem Pharmacol; 1994 Feb; 47(4):673-8. PubMed ID: 8129744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin K and coumarin anticoagulants: dependence of anticoagulant effect on inhibition of vitamin K transport.
    Lowenthal J; Birnbaum H
    Science; 1969 Apr; 164(3876):181-3. PubMed ID: 5774189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal variation in the effects of warfarin on the vitamin K cycle.
    Soulban G; Labrecque G; Bélanger PM
    Chronobiol Int; 1990; 7(5-6):403-11. PubMed ID: 2097073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Warfarin resistance. Vitamin K epoxide reductase of Scottish resistance genes is not irreversibly blocked by warfarin.
    Thijssen HH
    Biochem Pharmacol; 1987 Sep; 36(17):2753-7. PubMed ID: 3632704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microsomal warfarin binding and vitamin K 2,3-epoxide reductase.
    Thijssen HH; Baars LG
    Biochem Pharmacol; 1989 Apr; 38(7):1115-20. PubMed ID: 2706010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. R- and S-Warfarin inhibition of vitamin K and vitamin K 2,3-epoxide reductase activities in the rat.
    Fasco MJ; Principe LM
    J Biol Chem; 1982 May; 257(9):4894-901. PubMed ID: 7068669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and structure-activity relationships of novel warfarin derivatives.
    Gebauer M
    Bioorg Med Chem; 2007 Mar; 15(6):2414-20. PubMed ID: 17275317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inhibitory effect of calumenin on the vitamin K-dependent gamma-carboxylation system. Characterization of the system in normal and warfarin-resistant rats.
    Wajih N; Sane DC; Hutson SM; Wallin R
    J Biol Chem; 2004 Jun; 279(24):25276-83. PubMed ID: 15075329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue distribution and warfarin sensitivity of vitamin K epoxide reductase.
    Hazelett SE; Preusch PC
    Biochem Pharmacol; 1988 Mar; 37(5):929-34. PubMed ID: 3345202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the purified vitamin K-dependent gamma-glutamyl carboxylase.
    Morris DP; Soute BA; Vermeer C; Stafford DW
    J Biol Chem; 1993 Apr; 268(12):8735-42. PubMed ID: 8473318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of vitamin K epoxidase by two non-coumarin anticoagulants.
    Willingham AK; Laliberte RE; Bell RG; Matschiner JT
    Biochem Pharmacol; 1976 May; 25(9):1063-6. PubMed ID: 1267851
    [No Abstract]   [Full Text] [Related]  

  • 34. Coumarins and the vitamin K-K epoxide cycle. Lack of resistance to coumatetralyl in warfarin-resistant rats.
    Bell RG; Caldwell PT; Holm EE
    Biochem Pharmacol; 1976 May; 25(9):1067-70. PubMed ID: 1267852
    [No Abstract]   [Full Text] [Related]  

  • 35. Formation of hydroxyvitamin K by vitamin K epoxide reductase of warfarin-resistant rats.
    Fasco MJ; Preusch PC; Hildebrandt E; Suttie JW
    J Biol Chem; 1983 Apr; 258(7):4372-80. PubMed ID: 6833262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1,25-Dihydroxyvitamin D3 promotes vitamin K2 metabolism in human osteoblasts.
    Miyake N; Hoshi K; Sano Y; Kikuchi K; Tadano K; Koshihara Y
    Osteoporos Int; 2001; 12(8):680-7. PubMed ID: 11580082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Warfarin resistance is associated with a protein component of the vitamin K 2,3-epoxide reductase enzyme complex in rat liver.
    Cain D; Hutson SM; Wallin R
    Thromb Haemost; 1998 Jul; 80(1):128-33. PubMed ID: 9684798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between the vitamin K cycle inhibition and the plasma anticoagulant response at steady-state S-warfarin conditions in the rat.
    Mosterd JJ; Thijssen HH
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1081-5. PubMed ID: 1545379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin.
    Rost S; Fregin A; Hünerberg M; Bevans CG; Müller CR; Oldenburg J
    Thromb Haemost; 2005 Oct; 94(4):780-6. PubMed ID: 16270630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes.
    Fasco MJ; Principe LM; Walsh WA; Friedman PA
    Biochemistry; 1983 Nov; 22(24):5655-60. PubMed ID: 6652076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.